Yasuhisa Terao

High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Kosuke Yoshihara, Tatsuhiko Tsunoda, Daichi Shigemizu et al. · Clinical Cancer Research · 2012 · 196 citations · Full text

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Toru Sugiyama, Aikou Okamoto, Takayuki Enomoto et al. · Journal of Clinical Oncology · 2016 · 139 citations

Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations

Satoshi Inoue, Yasushi Hirota, Toshihide Ueno et al. · Nature Communications · 2019 · 127 citations · Full text

Prevalence of Uterine and Adnexal Involvement in Pulmonary Lymphangioleiomyomatosis

Takuo Hayashi, Toshio Kumasaka, Keiko Mitani et al. · The American Journal of Surgical Pathology · 2011 · 109 citations

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma

Hiroaki Itamochi, Tetsuro Oishi, Nao Oumi et al. · British Journal of Cancer · 2017 · 106 citations · Full text